Rizatriptan Tablet, Film Coated
Product Images NDC 71335-2980

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rizatriptan (NDC 71335-2980). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352980)

Label (Lbl713352980)
This text contains information about Rizatriptan Benzoate tablets, stating that each tablet contains 14.563 mg of Rizatriptan Benzoate, USP equivalent to 10 mg Rizatriptan. It also provides instructions for usage, dosage, storage conditions (20° to 25°C), and warns to keep the drugs out of the reach of children. The text includes an NDC number, manufacturing information, and a mention to scan the package insert QR code for prescribing information. It specifies that the medication guide should be dispensed to each patient. Lastly, it mentions the tablets are for prescription use only.*
FDA Label Image

Fig-5 (Rizatriptan Fct Figure 5)

Fig-5 (Rizatriptan Fct Figure 5)
Not available.*
FDA Label Image

1 (Rizatriptan Figure One)

1 (Rizatriptan Figure One)
This text provides information on the estimated probability of response to different medications over a period of time post-dose. It compares the response rates between Placebo, Rizatriptan Benzoate Tablets 5 mg, and Rizatriptan Benzoate Tablets 10 mg at 5 and 10 hours post-dose.*
FDA Label Image

1 (Rizatriptan Figure Two)

1 (Rizatriptan Figure Two)
This is a description of the estimated probability of remedicating or requiring rescue at different time intervals following the administration of different medications, including placebo and Rizatriptan Benzoate Tablets in 5 mg and 10 mg dosages. The data is presented in a table showing the likelihood of needing additional medication or rescue intervention at certain time points post-dose.*
FDA Label Image

1 (Rizatriptan Structure One)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.